| 000 | 00530nam a2200157Ia 4500 | ||
|---|---|---|---|
| 008 | 240807s9999||||xx |||||||||||||| ||und|| | ||
| 020 | _a9789696850366 | ||
| 100 | _aKhan, Hazar | ||
| 245 | 0 |
_aPharmacogenomics : _bExploring CYP2C9*2 varient in sulfonylurea treated type II diabetic patient / _cby Hazar Khan ; supervised by Mahayrookh Asif |
|
| 260 |
_aKarachi _c2018 |
||
| 650 | _aMasters of Philosophy | ||
| 650 | _aPharmacology | ||
| 700 | _aAsif, Mahayrookh | ||
| 710 | _aDow University of Health Science | ||
| 942 |
_bDMC _cTC |
||
| 999 |
_c32640 _d32640 |
||